BebeVida
BebéVida is a Porto-based Portuguese cryopreservation laboratory founded in 2004 that collects, processes, and stores umbilical cord blood and tissue stem cells for expecting families, holding dual AABB and FACT international accreditations unique in Portugal and Europe.
- Company typePrivate
- Founded2004
- HeadquartersPorto, Portugal
- Headcount11–50
- GTM typeB2C
- OfferingServices
What BebeVida does
BebéVida — formally Bebé Vida Ciências para a Vida, S.A. — is a Portuguese biotechnology company founded in 2004 and headquartered in Porto, with a secondary office in Lisbon. It operates the country's first and only cryopreservation laboratory dedicated to stem cells derived from umbilical cord blood and umbilical cord tissue, holding dual international accreditations from the AABB (Association for the Advancement of Blood & Biotherapies) and FACT (Foundation for Accreditation of Cellular Therapy) — a status no other laboratory in Portugal or Europe currently matches. The core technology centers on cryogenic long-term storage of hematopoietic and mesenchymal stem cells at extremely low temperatures, supported by advanced laboratory equipment and quality protocols authorized by the Portuguese Ministry of Health.
The company's product portfolio includes the primary cord blood and tissue cryopreservation service (Criopreservação de Células Estaminais), an end-to-end collection kit, the Maternal-Fetal Parallel Bank (Banco Materno-Fetal) storing maternal plasma, peripheral blood, baby plasma and cord fragments, Platelet Gel (Gel Plaquetário) from peripheral blood launched in 2013, and a complementary 4D ultrasound service (ECOmybaby). Samples are stored under contract for up to 25 years, with 100% compatibility for the child and 25% compatibility between siblings cited as functional benefits, alongside claims of potential utility against 80+ treatable diseases.
The business model combines a one-time processing fee (covering the cryopreservation kit, administration, and component validation) with recurring annual storage fees over the 25-year storage period. Distribution is primarily direct-to-consumer via phone, email, and an online service portal, supplemented by healthcare-professional referrals through hospitals and maternity wards, an insurance protocol with ASISA offering cost-free cryopreservation to eligible policyholders, and an institutional partnership with Caixa Geral de Depósitos. The company reaches expecting parents through content marketing, recurring events (Maratona da Maternidade, Simpósio da Grávida), social media (Facebook, Instagram, YouTube), and a long-running celebrity ambassador program. All operations are conducted within Portugal with no disclosed international expansion, and the company remains privately held with no external funding rounds identified.
BebeVida firmographics
Firmographics- Name
- BebeVida
- Legal name
- Bebé Vida Ciências para a Vida, S.A.
- Website
- https://bebevida.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- BebéVida is a Porto-based Portuguese cryopreservation laboratory founded in 2004 that collects, processes, and stores umbilical cord blood and tissue stem cells for expecting families, holding dual AABB and FACT international accreditations unique in Portugal and Europe.
- Ownership category
- akta.pro rank
BebeVida industry classification
Industry- Product category
- Stem Cell Cryopreservation Services
- NAICS
- Blood and Organ Banks (621991), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)
- akta.pro secondary industries
- Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats) (HLAGAIAJ), Transfusion Medicine & Immunohematology (Blood Bank) (HLAFAMAG)
Keywords
Where BebeVida is headquartered
LocationHeadquarters
- HQ city
- Porto
- HQ country
- Portugal
- HQ region
- Europe
Offices2 records
Markets served
BebeVida business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- Cryopreservation Services: One-time process opening fee includes cryopreservation kit, administrative services, and component validation. Annual storage fee for maintaining samples over 25-year storage period.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels6 records
BebeVida product offering
Product offeringCore offering
BebéVida operates a cryopreservation laboratory in Portugal that collects, processes, and stores hematopoietic and mesenchymal stem cells harvested from umbilical cord blood and tissue at the time of birth. The company also offers a parallel maternal-fetal bank storing maternal plasma, maternal peripheral blood, baby plasma, and cord fragments, complemented by platelet gel and 4D ultrasound services. Samples are stored in cryopreservation tanks for up to 25 years for potential future therapeutic use.
Product overview
BebéVida operates as a cryopreservation laboratory offering stem cell banking services from umbilical cord blood and tissue. The core service is Criopreservação de Células Estaminais, which includes a collection kit, laboratory processing, cryopreservation, and 25-year storage. The product portfolio is complemented by the Banco Materno-Fetal (Maternal-Fetal Bank), which stores additional biological products including maternal plasma, peripheral blood, baby plasma, and cord fragments. Additional services include ECOmybaby (4D ultrasound) and Gel Plaquetário (platelet gel from peripheral blood). The company operates in partnership with ASISA for cost-free cryopreservation programs.
Differentiator
Problem solved
Functional benefit
Products and services
- Criopreservação de Células Estaminais (Stem Cell Cryopreservation) Core cryopreservation service for hematopoietic stem cells from umbilical cord blood and mesenchymal stem cells from umbilical cord tissue, collected at birth and stored for up to 25 years for potential future therapeutic use in treating 80+ diseases.
- Kit de Criopreservação (Cryopreservation Kit) Collection kit delivered to expecting families before birth, used by healthcare professionals at the delivery room to collect umbilical cord blood and/or tissue samples and transport them safely to the laboratory for processing and storage.
- Banco Materno-Fetal / Banco Paralelo (Maternal-Fetal Parallel Bank) Parallel biological banking service that stores maternal plasma, maternal peripheral blood, baby plasma, and umbilical cord fragments alongside cord blood and tissue, creating a comprehensive maternal-fetal biological bank for potential future therapeutic applications.
- Gel Plaquetário (Platelet Gel from Peripheral Blood) Platelet gel obtained from peripheral blood, a biological product for therapeutic applications, launched as an expansion of BebéVida's service portfolio.
- ECOmybaby (4D Ultrasound) 4D ultrasound service providing emotional bonding experiences between expecting parents and their babies before birth, offered as a complementary maternity service.
Quantifiable outcome
- 60,000+ therapies performed using cryopreserved stem cells
- +2 more outcomes
Companies that use BebeVida
Customer profileNamed customers3 records
Segments2 records
Ideal customer profiles2 records
BebeVida technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
BebeVida partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- ASISAcoreHealth insurance protocol offering cost-free cryopreservation services to ASISA policyholders. Enables families with ASISA insurance to preserve their baby's stem cells without costs.
- Caixa Geral de Depósitos (CGD)minorInstitutional partners and customers of Caixa Geral de Depósitos receive special conditions for cryopreservation services.
- Make-A-Wish PortugalminorCharitable partnership for childhood cancer awareness campaigns. Created solidarity mascots for International Day of Children with Cancer (February 15).
- BabyFirstminorPartnership for sharing customer data with BabyFirst partners for special offers and campaigns related to maternity and infant services.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
BebeVida competitors and assessment
Company assessmentRegional players
- Cells4Life: Cells4Life is one of the UK's largest private cord blood and tissue banks, offering whole cord blood and cord tissue storage. Regional European peer operating in the same family banking category as BebeVida.
- FamiCord: FamiCord is the largest cord blood bank in Europe by sample volume, operating across multiple EU countries through subsidiaries including Polski Bank Komórek Macierzystych (PBKM). Major European competitor with broader geographic reach than BebeVida.
- Future Health Biobank: Future Health Biobank is a UK-headquartered private stem cell bank offering cord blood, cord tissue, and dental pulp storage across multiple European markets. Comparable European peer in the family banking category.
- Smart Cells International: Smart Cells is a UK-based private cord blood bank with international operations, including collection services in multiple countries. Regional European peer in family cord blood banking.
Direct peers
- Cord Blood Registry (CBR): CBR is among the largest private family cord blood banks in the world, providing collection kit, processing, and storage services. A close direct competitor to BebeVida's core offering, though operating primarily in the North American market.
- Americord Registry: Americord is a US-based private cord blood and tissue bank offering CryoMaxx processing technology and family banking services. Comparable to BebeVida's premium family banking positioning.
- Cryo-Cell International: Cryo-Cell International is one of the largest and longest-operating private cord blood banks globally, offering umbilical cord blood and tissue cryopreservation services to families. Direct competitor to BebeVida in the family cord blood banking market.
- StemCyte: StemCyte operates both public and private cord blood banking programs internationally with AABB and FACT accreditations. Highly comparable to BebeVida given overlapping regulatory accreditations and cord blood banking focus.
- ViaCord: ViaCord is a US-based private cord blood and cord tissue bank serving expecting families with collection, processing, and long-term cryopreservation services. Operates in a comparable family-focused D2C banking model to BebeVida.
Others
- CEVEC Pharmaceuticals: CEVEC is a bioprocessing company specializing in cell and gene therapy manufacturing, including cell banking infrastructure. Adjacent rather than directly competing, but provides broader context on the European cell therapy ecosystem in which BebeVida operates.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
BebeVida social profiles
Digital presenceBebeVida compliance and trust
Trust signalCompliance3 records
BebeVida financial estimates
Financial estimateRevenue estimate
Valuation estimate
BebeVida leadership team
Management profileNumber of profiles
Profiles2 records
BebeVida funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BebeVida M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BebeVida
What does BebeVida do?
BebéVida operates a cryopreservation laboratory in Portugal that collects, processes, and stores hematopoietic and mesenchymal stem cells harvested from umbilical cord blood and tissue at the time of birth. The company also offers a parallel maternal-fetal bank storing maternal plasma, maternal peripheral blood, baby plasma, and cord fragments, complemented by platelet gel and 4D ultrasound services. Samples are stored in cryopreservation tanks for up to 25 years for potential future therapeutic use.
Is BebeVida a public or private company?
BebeVida is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was BebeVida founded?
BebeVida was founded in 2004. It employs 11 to 50 people.
Where is BebeVida based?
BebeVida is headquartered in Porto, Portugal, in the Europe region.
How does BebeVida make money?
One revenue line is on record: cryopreservation Services.
Who are BebeVida's main competitors?
Regional players on record are Cells4Life, FamiCord, Future Health Biobank and Smart Cells International. Direct peers are Cord Blood Registry (CBR), Americord Registry, Cryo-Cell International, StemCyte and ViaCord. CEVEC Pharmaceuticals is listed as an others.
Does BebeVida have an API?
No public API is recorded for BebeVida.
What industry is BebeVida in?
BebeVida's product category is Stem Cell Cryopreservation Services. Its primary akta.pro industry code is HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue), with a secondary code of HLAGAIAJ, Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats). Its NAICS code is 621991 and its SIC code is 8071.